Virbac SA - Company Profile

Powered by

All the sales intelligence you need on Virbac SA in one solution.

$395 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Virbac SA fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Virbac SA.

Back to companies

Virbac SA: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Virbac SA (Virbac) is a veterinary healthcare company. The company develops and distributes pharmaceuticals, vaccines, and diagnostic tools for domestic animals and livestock. Its products include vaccines, antibiotics, parasiticides, dental products, nutrition, diagnosis, anti-inflammatory drugs, and dermatological products. Virbac’s products also include ear cleanser for dogs and cats; food supplement for cattle; tablets for the prevention of canine heartworm disease and treatment of roundworms and hookworms; and general anesthetics, among others. The company's products are utilized by veterinarians, farmers, and pet owners. It operates manufacturing, research, and development, and subsidiaries in Europe, North America, Latin America, Asia-Pacific, Africa, and the Middle East. Virbac is headquartered in Carros, Provence-Alpes-Cote d'Azur, France

 Gain a 360-degree view of Virbac SA and make more informed decisions for your business Gain a 360-degree view of Virbac SA and make more informed decisions for your business Learn more
Headquarters France
Address 13 Street LID BP 27, Carros, Provence - Alpes- Cote d'Azur, 06510
Website corporate.virbac.com
Telephone 33 492 087100
No of Employees 6,442
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange VIRP (EPA)
Revenue (2024) $1.7B 4.8% (2024 vs 2023)
EPS XYZ
Net Income (2024) XYZ 3.9% (2024 vs 2023)
Market Cap* $3.1B
Net Profit Margin (2024) XYZ -1.0% (2024 vs 2023)
* As of and is in US$
View Virbac SA financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Virbac SA premium industry data and analytics

1

Marketed Drugs

Understand Virbac SA’s commercialized product portfolio to stay one step ahead of the market.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Virbac SA’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Vaccines CaniLeish
Antibiotics Veterinary HPM
Parasiticides Cydectin Platinum
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Virbac SA portfolio and identify potential areas for collaboration Understand Virbac SA portfolio and identify potential areas for collaboration Learn more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2026 Contracts/Agreements In July, the company signed a partnership with Improve Veterinary Education to introduce an exclusive online training course designed for companion animal vaccination.
2026 Contracts/Agreements In March, the company partnered with MACSO to secure distribution rights for MACSO's AI swine health monitoring solution in Europe, Latin America, and Asia.
2025 Asset Purchase In December, the company acquired Thyronorm from Norbrook Laboratories Limited for GBP100 million.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Learn more
Image for loader

Competitor Comparison

Key Parameters Virbac SA Elanco Animal Health Inc Idexx Laboratories Inc Ceva Sante Animale SA Vetoquinol SA
Headquarters France United States of America United States of America France France
City Carros Indianapolis Westbrook Libourne Lure
State/Province Provence - Alpes- Cote d'Azur Indiana Maine Aquitaine Haute Normandie
No. of Employees 6,442 9,400 11,000 7,000 2,497
Entity Type Public Public Public Private Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Learn more
Executives
Name Position Board Since Age
Pierre Madelpuech Vice Chairman Executive Board 1995 65
Marie-Helene Dick-Madelpuech Chairwoman Executive Board 2020 61
Paul Martingell Chief Executive Officer Senior Management 2025 45
Habib Ramdani Executive Vice President; Chief Executive Officer - Deputy; Chief Financial Officer Senior Management 2016 49
Enguerrand Dubois Executive Vice President - Europe Region Senior Management - -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Virbac SA key executives to enhance your sales strategy Gain insight into Virbac SA key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?